astemizole has been researched along with Angiogenesis, Pathologic in 1 studies
Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lyu, J | 1 |
| Yang, EJ | 1 |
| Head, SA | 1 |
| Ai, N | 1 |
| Zhang, B | 1 |
| Wu, C | 1 |
| Li, RJ | 1 |
| Liu, Y | 1 |
| Chakravarty, H | 1 |
| Zhang, S | 1 |
| Tam, KY | 1 |
| Dang, Y | 1 |
| Kwon, HJ | 1 |
| Ge, W | 1 |
| Liu, JO | 1 |
| Shim, JS | 1 |
1 other study available for astemizole and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol Trafficking.
Topics: A549 Cells; Astemizole; Biological Transport; Blotting, Western; Cell Movement; Cell Proliferation; | 2018 |